-transparent.png){kind=logo}
The basal ganglia play a role in controlling movement during gait. The aim of the present study was to investigate changes in dopamine transporter (DAT) availability in the striatum and extrastriatal region in association with walking exercise in six normal subjects and seven age-matched unmedicated patients with Parkinson's disease. This was done by comparing DAT radioligand uptake in the dopaminergic projection areas after gait with that under the resting condition using a DAT probe, 11C-labelled 2-beta-carbomethoxy-3beta-(4-fluorophenyl) tropane ([11C]CFT) and PET. Physiological parameters were stable during and after gait in both groups. The regions of interest method for measuring differences in [11C]CFT uptake level and voxel-based statistical parametric mapping (SPM96) showed that [11C]CFT uptake in the striatum (specifically the putamen) was decreased by gait to a greater extent in normal subjects, whereas a significant reduction in [11C]CFT uptake was not found in the putamen but in the caudate and orbitofrontal cortex in Parkinson's disease patients. These results are the first in vivo evidence that DAT availability is reduced in the nigrostriatal projection area by basic human behaviour, i.e. gait. Alterations in this availability in Parkinson's disease suggested that shifted activation in the medial striatum and the mesocortical dopaminergic system might reflect the pathophysiology of parkinsonian gait.
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
April 2018,
Movement disorders : official journal of the Movement Disorder Society,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
May 1975,
Brain research,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
October 1981,
Brain research,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
December 2011,
Fortschritte der Neurologie-Psychiatrie,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
August 2025,
Neural regeneration research,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
January 1991,
Rivista di neurologia,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
January 2007,
Journal of neurology,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
September 2006,
Brain research,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
March 1983,
Behavioural brain research,
Y Ouchi, and
T Kanno, and
H Okada, and
E Yoshikawa, and
M Futatsubashi, and
S Nobezawa, and
T Torizuka, and
K Tanaka
January 1978,
Advances in biochemical psychopharmacology,
